Martin Fey, MD from the University of Bern, Bern, Switzerland provides an overview of his thought-provoking presentation on ‘The costs of care in hematological cancers: health economic issues’, given at the International Conference on Malignant Lymphoma (ICML) 2017 held in Lugano, Switzerland. Prof. Fey explains the different types of costs associated with hematological cancer, which are by no means limited to the cost of drugs alone. Discussing the process of validating novel drugs and the design of clinical trials, Prof. Fey makes interesting comments on how health economics can be improved upon.
